U.S. markets closed
  • S&P 500

    3,819.72
    -50.57 (-1.31%)
     
  • Dow 30

    31,270.09
    -121.43 (-0.39%)
     
  • Nasdaq

    12,997.75
    -361.04 (-2.70%)
     
  • Russell 2000

    2,207.79
    -23.72 (-1.06%)
     
  • Crude Oil

    61.06
    +1.31 (+2.19%)
     
  • Gold

    1,709.30
    -24.30 (-1.40%)
     
  • Silver

    26.18
    -0.70 (-2.60%)
     
  • EUR/USD

    1.2069
    -0.0019 (-0.16%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • GBP/USD

    1.3954
    -0.0003 (-0.02%)
     
  • USD/JPY

    106.9910
    +0.2810 (+0.26%)
     
  • BTC-USD

    51,051.84
    +3,252.67 (+6.80%)
     
  • CMC Crypto 200

    1,021.19
    +33.09 (+3.35%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Phathom Pharmaceuticals Inc (PHAT) COO Azmi Nabulsi Sold $578,405 of Shares

GuruFocus.com
·1 min read

- By insider

COO of Phathom Pharmaceuticals Inc (30-Year Financial, Insider Trades) Azmi Nabulsi (insider trades) sold 14,500 shares of PHAT on 02/02/2021 at an average price of $39.89 a share. The total sale was $578,405.


Phathom Pharmaceuticals Inc has a market cap of $1.2 billion; its shares were traded at around $42.780000 . GuruFocus has detected 1 severe warning sign with Phathom Pharmaceuticals Inc. .

Directors and Officers Recent Trades:

  • COO Azmi Nabulsi sold 14,500 shares of PHAT stock on 02/02/2021 at the average price of $39.89. The price of the stock has increased by 7.24% since.

  • Director David A Socks sold 40,000 shares of PHAT stock on 01/12/2021 at the average price of $35.7. The price of the stock has increased by 19.83% since.

For the complete insider trading history of PHAT, click here

.This article first appeared on GuruFocus.